A detailed history of Sterling Capital Management LLC transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Sterling Capital Management LLC holds 47,785 shares of ASND stock, worth $5.94 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
47,785
Previous 60,580 21.12%
Holding current value
$5.94 Million
Previous $5.84 Million 122175.54%
% of portfolio
0.09%
Previous 0.06%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$113.0 - $153.43 $1.45 Million - $1.96 Million
-12,795 Reduced 21.12%
47,785 $7.13 Billion
Q3 2019

Nov 14, 2019

BUY
$95.8 - $118.9 $5.8 Million - $7.2 Million
60,580 New
60,580 $5.84 Million

Others Institutions Holding ASND

About Ascendis Pharma A/S


  • Ticker ASND
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,810,200
  • Market Cap $6.94B
  • Description
  • Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...
More about ASND
Track This Portfolio

Track Sterling Capital Management LLC Portfolio

Follow Sterling Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sterling Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sterling Capital Management LLC with notifications on news.